Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Sosei to Get £5 Million Milestone Payment from GSK as GI Drug Program Progresses
December 21, 2021
- Eisai Snags Rights to Gilead’s JAK Inhibitor Jyseleca in 4 Asian Markets
December 21, 2021
- Biogen Halves US Price Tag on Aduhelm to Improve Patient Access
December 21, 2021
- Astellas to Abolish Pay Structure for Sales Reps, Switching to Company-Wide System Next April
December 20, 2021
- Sosei, Twist Bioscience Hook Up on GPCR Antibodies
December 20, 2021
- Medicago Submits Final Vaccine Data for Canada’s COVID-19 Rolling Review
December 20, 2021
- Pfizer Agrees to Supply Oral COVID-19 Drugs for 2 Million People in Japan
December 20, 2021
- Nikhilesh Kalra to Head Up Sanofi’s Japan Consumer Unit from January
December 20, 2021
- Biogen to Challenge European Rejection of Aducanumab
December 20, 2021
- Otsuka Grabs Rights to Kyoto University Spinoff’s iPSC-Derived CAR-T/TCR-T Production Techs
December 17, 2021
- 27 Japan Drug Makers Foresee Stronger Growth in FY2021 vs Initial Forecast: Tally
December 17, 2021
- IND for Cancer Photoimmunotherapy RM-1995 Accepted in US: Rakuten Medical
December 17, 2021
- Chugai In-Licenses Sarepta’s DMD Gene Therapy from Roche
December 17, 2021
- Biogen/Eisai to Begin Aduhelm Confirmatory Study Next Year
December 17, 2021
- Chugai Terminates Development of Atea’s COVID-19 Drug in Japan
December 17, 2021
- Moderna to Develop All Global Pipeline Assets in Japan without Delay: Local Chief
December 17, 2021
- Shionogi Pharma Eyes 10 Billion Yen Sales in CDMO Business in FY2022
December 17, 2021
- Novavax’s COVID-19 Vaccine Filed in Japan: Takeda
December 16, 2021
- ADC Programs on a Roll, Daiichi Sankyo Got Off to Good Start towards Mid-Term Goal: CEO
December 16, 2021
- Maker FTC Issues “Warning” to Ono over Onoact Bribery Case
December 16, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…